Millennium Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8M | Buy |
910,841
+437,216
| +92% | +$6.13M | 0.01% | 1438 |
|
|
2025
Q1 | $7.41M | Sell |
473,625
-1,836,538
| -79% | -$28.7M | ﹤0.01% | 1717 |
|
|
2024
Q4 | $32.2M | Buy |
2,310,163
+1,162,690
| +101% | +$16.2M | 0.02% | 801 |
|
|
2024
Q3 | $10.7M | Buy |
1,147,473
+634,777
| +124% | +$5.9M | 0.01% | 1517 |
|
|
2024
Q2 | $4.77M | Buy |
512,696
+133,645
| +35% | +$1.24M | ﹤0.01% | 1960 |
|
|
2024
Q1 | $3.76M | Sell |
379,051
-2,179,829
| -85% | -$21.6M | ﹤0.01% | 2186 |
|
|
2023
Q4 | $8.27M | Buy |
2,558,880
+2,249,931
| +728% | +$7.27M | ﹤0.01% | 1593 |
|
|
2023
Q3 | $1.64M | Buy |
+308,949
| New | +$1.64M | ﹤0.01% | 2612 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4203 |
|
|
2023
Q1 | – | Sell |
-664,447
| Closed | -$9.83M | – | 4510 |
|
|
2022
Q4 | $9.83M | Buy |
664,447
+578,550
| +674% | +$8.56M | 0.01% | 1576 |
|
|
2022
Q3 | $1.64M | Buy |
+85,897
| New | +$1.64M | ﹤0.01% | 3013 |
|
|
2022
Q2 | – | Sell |
-100,126
| Closed | -$1.93M | – | 5072 |
|
|
2022
Q1 | $1.93M | Buy |
+100,126
| New | +$1.93M | ﹤0.01% | 3090 |
|
|
2021
Q4 | – | Sell |
-30,618
| Closed | -$731K | – | 5150 |
|
|
2021
Q3 | $731K | Buy |
+30,618
| New | +$731K | ﹤0.01% | 3891 |
|
|
2021
Q2 | – | Sell |
-15,093
| Closed | -$437K | – | 4971 |
|
|
2021
Q1 | $437K | Sell |
15,093
-145,001
| -91% | -$4.2M | ﹤0.01% | 3731 |
|
|
2020
Q4 | $4.5M | Buy |
160,094
+129,452
| +422% | +$3.64M | ﹤0.01% | 1983 |
|
|
2020
Q3 | $898 | Buy |
30,642
+4,703
| +18% | +$138 | ﹤0.01% | 2545 |
|
|
2020
Q2 | $784K | Buy |
25,939
+14,055
| +118% | +$425K | ﹤0.01% | 2511 |
|
|
2020
Q1 | $354K | Buy |
+11,884
| New | +$354K | ﹤0.01% | 2465 |
|